Northwestern Mutual Wealth Management’s Co-Diagnostics CODX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3	Buy	+1	New	+$3	﹤0.01%	4070
2024 Q4	–	Sell	-3	Closed	-$125	–	3657
2024 Q3	$125	Buy	+3	New	+$115	﹤0.01%	3477
2023 Q2	–	Hold	0	–	-$1	–	3381
2023 Q1	–	Hold	0	–	–	–	3336
2022 Q1	–	Sell	-33	Closed	-$9K	–	3144
2021 Q4	$9K	Buy	+33	New	+$8.66K	﹤0.01%	2590

Other funds holding CODX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAG

Private Advisory Group Redmond, Washington $1.85B AUM 50.66% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northwestern Mutual Wealth Management's CODX Position: Q2 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Co-Diagnostics (CODX) in Q2 2026: 1 share worth $3. The stake represents ﹤0.01% of the portfolio and ranks #4070 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in CODX as recently as Q3 2024.

Northwestern Mutual Wealth Management first reported a position in CODX in Q4 2021 and has held it in 3 quarters since. The position peaked at $9K in Q4 2021. 24 funds tracked by Wall St. Rank hold CODX as of Q2 2026.

Northwestern Mutual Wealth Management held 1 share of Co-Diagnostics worth $3 as of Q2 2026.
Co-Diagnostics was a new Northwestern Mutual Wealth Management position in Q2 2026.
Co-Diagnostics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #4070 holding.
Northwestern Mutual Wealth Management first reported a position in Co-Diagnostics in Q4 2021 and has held it in 3 quarters since.
Northwestern Mutual Wealth Management's Co-Diagnostics position peaked at $9K in Q4 2021.
24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.